Delivery Order SPE2DB22D1017-SPE2DB24FF3WY
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,589.11 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565057997 Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply VIVITROL 380 MG VIAL-DILUENTS. The $2,269.15 order, which has no set-aside designation, is to be completed by December 26, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced provider of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,990.81 and an ultimate completion date of August 9, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The contract is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $5,817.72 and a period of performance through April 3, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,861.09 and an ultimate completion date of August 14, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications, vaccines, and medical supplies, to...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $2,418.54. The contract has an ultimate completion date of April 23, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is a delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $5,485.86 firm fixed-price contract is for the supply of 380 mg Vivitrol vials and diluents, a medication used for the treatment of opioid and alcohol dependence. The contract has an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,930.54, is a delivery order for VIVITROL 380 MG VIAL-DILUENTS. It is a firm fixed-price contract with a period of performance through November 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3WYDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $2,610.24, is for the delivery of Vivitrol 380 mg vials with diluents. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract supports the provision of a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/7/24 |